Differentiating Reactive from Concerning Causes of Chronic Intermittent Leukocytosis
The most important step in differentiating reactive from concerning causes of chronic intermittent leukocytosis is to perform a thorough peripheral blood smear examination and evaluate the pattern of leukocytosis, including cell types, morphology, and associated blood count abnormalities.
Initial Evaluation
- Examine the peripheral blood smear to identify the predominant cell type (neutrophils, lymphocytes, monocytes, etc.) and assess cell morphology, which can provide crucial diagnostic clues 1, 2
- Review the pattern and degree of leukocytosis - reactive causes typically show moderate elevations, while malignant causes may show more extreme or progressive elevations 2, 3
- Check for abnormalities in other cell lines - concurrent anemia or thrombocytopenia increases suspicion for a primary bone marrow disorder 2
- Determine if the leukocytosis is isolated or associated with other symptoms such as fever, weight loss, night sweats, or lymphadenopathy 3
Distinguishing Features of Reactive Leukocytosis
- Reactive leukocytosis typically shows predominance of mature neutrophils with a mild "left shift" (presence of band forms) 2
- Common reactive causes include:
- Reactive leukocytosis typically resolves when the underlying cause is treated 4
Warning Signs of Malignant Causes
- Extreme elevations in white blood cell count (>50,000/μL) without clear infectious or inflammatory cause 3
- Abnormal cell morphology on peripheral smear (blasts, immature forms, dysplastic changes) 4
- Progressive increases in white blood cell count over time 2
- Concurrent abnormalities in red blood cell or platelet counts 2
- Constitutional symptoms (fever, weight loss, night sweats) 3
- Hepatomegaly, splenomegaly, or lymphadenopathy on physical examination 2
- Persistent leukocytosis after resolution of apparent inciting factors 4
Specific Evaluation for Chronic Lymphocytic Leukemia (CLL)
- CLL should be suspected with persistent lymphocytosis ≥5 × 10^9/L (5,000/μL) not explained by other disorders 5
- Characteristic findings on peripheral smear include predominance of small, mature-appearing lymphocytes 5
- Flow cytometry showing the composite immunophenotype (CD5+, CD19+, CD20+ (low), CD23+, sIg low, CD79b low) can distinguish CLL from other lymphoproliferative disorders 5
- Bone marrow examination may be informative in patients older than 60 years or those with systemic symptoms 6
Monitoring and Management
- For patients with suspected reactive leukocytosis:
- For patients with suspected malignant causes:
Important Caveats
- The absolute white blood cell count alone should not be the sole criterion for determining whether leukocytosis is reactive or malignant 5
- Even markedly elevated white blood cell counts in chronic leukemias like CLL rarely cause symptoms related to leukocyte aggregates, unlike in acute leukemias 5
- Treatment decisions in CLL should be based on disease-related symptoms and progressive disease rather than absolute lymphocyte count alone 5
- Progressive lymphocytosis with an increase of more than 50% over a 2-month period or lymphocyte doubling time of less than 6 months may indicate need for treatment in CLL 5